Zobrazeno 1 - 10
of 86
pro vyhledávání: '"Ostrov Cs"'
Autor:
William C. Stewart, Rosanelli Eg, Elaine P. Kelley, Iacono Tl, John C. Lue, Croyle Ta, Alan S. Crandall, Beehler Cc, Ostrov Cs, Macdonald Dk
Publikováno v:
Journal of Glaucoma. 1:237-242
Treatment with noncardioselective beta-adrenoceptor antagonists (e.g., 0.5% timolol or 0.5% levobunolol) is standard practice for lowering elevated intraocular pressure (IOP). However, because there are risks and side effects associated with the use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::836b452336cc7a9cea7a98bbb9492d16
https://doi.org/10.1097/00061198-199201040-00005
https://doi.org/10.1097/00061198-199201040-00005
Publikováno v:
Journal of Glaucoma. 7:395
Purpose To evaluate the safety of open-label 2.0% dorzolamide as monotherapy and when used with timolol and/or pilocarpine for as long as 2 years. Methods The safety of dorzolamide was evaluated in patients with open-angle glaucoma or ocular hyperten
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00028f53dece09ee82cf25611bc2e3ca
https://doi.org/10.1097/00061198-199812000-00007
https://doi.org/10.1097/00061198-199812000-00007
Autor:
Delgado, Esmeralda1,2,3 (AUTHOR) esmeralda@fmv.ulisboa.pt, Gomes, Érica3 (AUTHOR), Gil, Solange1,2,3 (AUTHOR), Lourenço, Ana Mafalda1,2,3 (AUTHOR)
Publikováno v:
BMC Veterinary Research. 2/3/2023, Vol. 19 Issue 1, p1-11. 11p. 3 Color Photographs, 1 Chart, 2 Graphs.
Autor:
Adamsons IA; Department of Clinical Research, Merck Research Laboratories, West Point, Pennsylvania, USA., Polis A, Ostrov CS, Boyle JE
Publikováno v:
Journal of glaucoma [J Glaucoma] 1998 Dec; Vol. 7 (6), pp. 395-401.
Autor:
Tauber J; Felix N. Sabatesi Associates, Prairie Village, Kansas, USA., Raizman MB, Ostrov CS, Laibovitz RA, Abelson MB, Betts JG, Koester JM, Gill D, Schaich L
Publikováno v:
Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics [J Ocul Pharmacol Ther] 1998 Apr; Vol. 14 (2), pp. 137-45.
Autor:
Ostrov CS; University of Minnesota, Phillips Eye Institute, Minneapolis, USA., Sirkin SR, Deutsch WE, Masi RJ, Chandler JW, Lindquist TD
Publikováno v:
Clinical therapeutics [Clin Ther] 1997 Mar-Apr; Vol. 19 (2), pp. 259-72.
Autor:
Zhou, Xiaoyu1,2 (AUTHOR), Zhang, Xinyue1,2 (AUTHOR), Zhou, Dengming2 (AUTHOR), zhao, Yang1,2 (AUTHOR), Duan, Xuanchu1,3 (AUTHOR) duanxchu@csu.edu.cn
Publikováno v:
Ophthalmology & Therapy. Oct2022, Vol. 11 Issue 5, p1681-1704. 24p.
Autor:
Talley AR; Phillips Eye Institute Center for Teaching and Research, University of Minnesota, Minneapolis., Hardten DR, Sher NA, Kim MS, Doughman DJ, Carpel E, Ostrov CS, Lane SS, Parker P, Lindstrom RL
Publikováno v:
American journal of ophthalmology [Am J Ophthalmol] 1994 Sep 15; Vol. 118 (3), pp. 304-11.
Autor:
Beehler CC; Private practice, Ft. Myers, Florida; †Medical University of South Carolina, Charleston, South Carolina; ‡University of Utah, Salt Lake City, Utah; §Nalle Clinic, Charlotte, North Carolina; ∥Phillips Eye Institute, Minneapolis, Minnesota; ¶University of South Florida, Tampa, Florida; and # Allergan, Inc., Irvine, California, U.S.A., Stewart WC, Macdonald DK, Croyle TA, Ostrov CS, Rosanelli EG, Crandall AS, Iacono TL, Lue JC, Kelley EP
Publikováno v:
Journal of glaucoma [J Glaucoma] 1992 Winter; Vol. 1 (4), pp. 237-42.
Autor:
Zabel RW; Phillips Eye Institute, Minneapolis, Minn., Sher NA, Ostrov CS, Parker P, Lindstrom RL
Publikováno v:
Refractive & corneal surgery [Refract Corneal Surg] 1990 Sep-Oct; Vol. 6 (5), pp. 329-34.